Expedited Kilolab Development of AZD7624 Using Kulinkovich-de Meijere Cyclopropanation

Author:

Ashok Mithun1,J Ashwini D.1,Leuser Helena2,Malapati Ajaya K.1,Parker Jeremy S.1ORCID,Rowley Naomi A.3,Steven Alan3ORCID,Timms Lee1,Tyler Simon N. G.3,Whitmarsh Samuel3

Affiliation:

1. Early Chemical Development, Pharmaceutical Sciences, AstraZeneca R&D, Macclesfield SK10 2NA, U.K.

2. Chemical Development, Carbogen Amcis AG, Hunzenschwil CH-5502, Switzerland

3. Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, U.K.

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Reference42 articles.

1. Emerging role of MAP kinase pathways as therapeutic targets in COPD

2. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells

3. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial

4. Cooper, A. E.; Luker, T. J.; Schmidt, J. A. Preparation of pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient. WO 2010071583 A1, 2010.

5. Brough, S.; Evans, R.; Luker, T. J.; Raubo, P. Pyrazinone derivatives and their use in the treatment of lung diseases and their preparation. WO 2009001132 A1, 2008.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Organotitanium and Organozirconium Reagents;Reference Module in Chemistry, Molecular Sciences and Chemical Engineering;2024

2. Practical and Scalable Method for Manufacturing AZD4604, A Potent and Selective JAK1 Inhibitor;Organic Process Research & Development;2023-06-15

3. Ni-Catalyzed Reductive Cross-Coupling of Cyclopropylamines and Other Strained Ring NHP Esters with (Hetero)Aryl Halides;Organic Letters;2022-11-09

4. Synthesis of AZD7624;Synfacts;2021-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3